Peak6 Investments LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Peak6 Investments LLC

$37.5 Billion
Q2 2024

Put Options

24 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $3.18 Million - $3.86 Million	-3,600 Reduced 25.71%	10,400 $10.9 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $15.9 Million - $17.5 Million	-17,600 Reduced 55.7%	14,000 $13.5 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $4.03 Million - $4.58 Million	5,200 Added 19.7%	31,600 $27.8 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $2.98 Million - $3.63 Million	-4,300 Reduced 14.01%	26,400 $21.7 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $7.14 Million - $8.47 Million	-10,200 Reduced 24.94%	30,700 $22.1 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $16.7 Million - $20.3 Million	24,500 Added 149.39%	40,900 $33.6 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $10.6 Million - $11.5 Million	-15,000 Reduced 47.77%	16,400 $11.8 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $28.2 Million - $35.6 Million	-49,200 Reduced 61.04%	31,400 $21.6 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $16.6 Million - $22.4 Million	-30,300 Reduced 27.32%	80,600 $47.6 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $15.1 Million - $17.7 Million	-25,400 Reduced 18.64%	110,900 $77.5 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $20.8 Million - $25.6 Million	38,200 Added 38.94%	136,300 $86.1 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $21.4 Million - $25.4 Million	37,336 Added 61.44%	98,100 $59.4 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $206,140 - $243,523	-436 Reduced 0.71%	60,764 $37.5 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $4.33 Million - $5.32 Million	9,700 Added 18.83%	61,200 $29 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $3.54 Million - $4.5 Million	7,400 Added 16.78%	51,500 $24.9 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $817,125 - $987,315	1,500 Added 3.52%	44,100 $24.7 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $2.22 Million - $2.9 Million	-4,500 Reduced 9.55%	42,600 $26.6 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $7.09 Million - $10.4 Million	-21,100 Reduced 30.94%	47,100 $23 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $6.06 Million - $8.32 Million	22,100 Added 47.94%	68,200 $25.6 Million
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $4.05 Million - $4.71 Million	-14,800 Reduced 24.3%	46,100 $12.8 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $5.03 Million - $6.97 Million	16,800 Added 38.1%	60,900 $19.1 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $148,832 - $175,828	400 Added 0.92%	44,100 $18.1 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $1.48 Million - $1.77 Million	-4,400 Reduced 9.15%	43,700 $16.3 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $16.9 Million - $19.6 Million	48,100 New	48,100 $19.4 Million

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

Vanguard Group Inc Valley Forge, PA

8.99M
Shares

$9.37 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$8.8 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

8.28M
Shares

$8.63 Billion
0.77% of portfolio
State Street Corp Boston, MA

4.84M
Shares

$5.05 Billion
0.23% of portfolio
Capital World Investors Los Angeles, CA

4.64M
Shares

$4.83 Billion
0.82% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account